Please login to the form below

Not currently logged in
Email:
Password:

Boston Pharmaceuticals

This page shows the latest Boston Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

Boston, Mass-based Karuna Pharmaceuticals is focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders marked by psychosis and cognitive impairment.

Latest news

  • J&J adds Israel to list of bioincubators J&J adds Israel to list of bioincubators

    groups. Meanwhile, alongside its own offices J&J is also forging collaborations with established bioincubators in Montreal, Toronto, San Francisco and Boston. ... Boston has added programmes with Assembly Pharmaceuticals on viral infections and Nodality

  • Scratching the surface

    Japan. Azithromycin . Zmax SR (Pfizer). Migraine. US. Bazedoxifene . Viviant; Conbriza (Pfizer)  . Postmenopausal osteoporosis. Japan, Spain. Carbohydrate polymer . TAXUS Element (Angiotech Pharmaceuticals/Boston Scientific Corporation).

  • A brighter future

    Epiduo (Galderma). Acne. UK. Rifaximin 550mg tablets. Xifaxan (Salix Pharmaceuticals). Overt hepatic encephalopathy (HE) recurrence. ... CAMBIA (Nautilus Neurosciences). Migraine. US. Paclitaxel-eluting coronary stent systems. TAXUS Element (Angiotech

  • News in brief, June 07, 2007

    FWP which is majority controlled by Frostrow Capital and is managed from Boston by US pharmaceuticals manager Sam Islay from Orbimed Advisers. ... In March 2007, Barr Pharmaceuticals made a Paragraph IV challenge against Otsuka regarding the aripiprazole

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Vertex poaches new finance chief from Ironwood Pharmaceuticals Vertex poaches new finance chief from Ironwood Pharmaceuticals

    Boston-based biotech company appoints Tom Graney. Vertex lured Tom Graney away from Ironwood Pharmaceuticals, appointing him as its new senior vice president and chief financial officer. ... Graney most recently spent three years at Ironwood

  • Juniper Pharmaceuticals adds to board of directors Juniper Pharmaceuticals adds to board of directors

    Mary Ann Gray joins as audit committee chair. Boston-based Juniper Pharmaceuticals has elected Mary Ann Gray to its board of directors and appointed her as its audit committee chair. ... Dr Gray has over 20 years of biotechnology and biopharmaceutical

  • Boston Pharma appoints ex-Pfizer and Sanofi executives Boston Pharma appoints ex-Pfizer and Sanofi executives

    Santiago Arroyo and Constantine Chinoporos join its senior team. Boston Pharmaceuticals has appointed Santiago Arroyo as chief medical officer and Constantine Chinoporos as chief business officer to further build and develop ... He said: “Boston

  • Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head

    Moves to the Boston company from Onyx Pharmaceuticals. Boston-based biopharmaceutical firm Intarcia Therapeutics has appointed Dr Sunita Zalani as vice president, global head of regulatory affairs and quality. ... She joins the company from Amgen's Onyx

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics